{"resourceType": "Citation", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation"], "versionId": "12", "lastUpdated": "2025-10-12T09:15:30.172Z"}, "contained": [{"resourceType": "Practitioner", "id": "contributor0", "name": [{"family": "Sweeney", "given": ["Christopher J"]}]}, {"resourceType": "Practitioner", "id": "contributor1", "name": [{"family": "Chen", "given": ["Yu-Hui"]}]}, {"resourceType": "Practitioner", "id": "contributor2", "name": [{"family": "Carducci", "given": ["Michael"]}]}, {"resourceType": "Practitioner", "id": "contributor3", "name": [{"family": "Liu", "given": ["Glenn"]}]}, {"resourceType": "Practitioner", "id": "contributor4", "name": [{"family": "Jarrard", "given": ["David F"]}]}, {"resourceType": "Practitioner", "id": "contributor5", "name": [{"family": "Eisenberger", "given": ["Mario"]}]}, {"resourceType": "Practitioner", "id": "contributor6", "name": [{"family": "Wong", "given": ["Yu-Ning"]}]}, {"resourceType": "Practitioner", "id": "contributor7", "name": [{"family": "Hahn", "given": ["Noah"]}]}, {"resourceType": "Practitioner", "id": "contributor8", "name": [{"family": "Kohli", "given": ["Manish"]}]}, {"resourceType": "Practitioner", "id": "contributor9", "name": [{"family": "Cooney", "given": ["Matthew M"]}]}, {"resourceType": "Practitioner", "id": "contributor10", "name": [{"family": "Dreicer", "given": ["Robert"]}]}, {"resourceType": "Practitioner", "id": "contributor11", "name": [{"family": "Vogelzang", "given": ["Nicholas J"]}]}, {"resourceType": "Practitioner", "id": "contributor12", "name": [{"family": "Picus", "given": ["Joel"]}]}, {"resourceType": "Practitioner", "id": "contributor13", "name": [{"family": "Shevrin", "given": ["Daniel"]}]}, {"resourceType": "Practitioner", "id": "contributor14", "name": [{"family": "Hussain", "given": ["Maha"]}]}, {"resourceType": "Practitioner", "id": "contributor15", "name": [{"family": "Garcia", "given": ["Jorge A"]}]}, {"resourceType": "Practitioner", "id": "contributor16", "name": [{"family": "DiPaola", "given": ["Robert S"]}]}, {"resourceType": "ArtifactAssessment", "id": "meshHeading0", "artifactReference": {"reference": "#", "type": "Citation"}, "content": [{"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000328", "display": "Adult", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000368", "display": "Aged", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000369", "display": "Aged, 80 and over", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000726", "display": "Androgen Antagonists", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000009", "display": "adverse effects"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000970", "display": "Antineoplastic Agents", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000009", "display": "adverse effects"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000077143", "display": "Docetaxel", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D004359", "display": "Drug Therapy, Combination", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D005500", "display": "Follow-Up Studies", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D006801", "display": "Humans", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D053208", "display": "Kaplan-Meier Estimate", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D008297", "display": "Male", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D008875", "display": "Middle Aged", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D009503", "display": "Neutropenia", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000139", "display": "chemically induced"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000453", "display": "epidemiology"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D017430", "display": "Prostate-Specific Antigen", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000097", "display": "blood"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D011471", "display": "Prostatic Neoplasms", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000188", "display": "drug therapy"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000401", "display": "mortality"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000473", "display": "pathology"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D043823", "display": "Taxoids", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000009", "display": "adverse effects"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}]}]}], "useContext": [{"code": {"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code": "fevir-platform-use", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code": "medline-base", "display": "Medline Base", "userSelected": false}]}}], "classification": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code": "citation-source", "display": "Citation Source"}]}, "classifier": [{"text": "MEDLINE"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code": "medline-owner", "display": "MEDLINE Citation Owner"}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "code": "NLM", "display": "National Library of Medicine, Index Section", "userSelected": false}]}]}], "statusDate": [{"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-entrez", "display": "PubMed Pubstatus of Entrez"}]}, "period": {"end": "2015-08-06T06:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-pubmed", "display": "PubMed Pubstatus of Pubmed"}]}, "period": {"end": "2015-08-06T06:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-medline", "display": "PubMed Pubstatus of Medline"}]}, "period": {"end": "2015-08-26T06:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-pmc-release", "display": "PubMed Pubstatus of PMC release"}]}, "period": {"end": "2016-02-20"}}], "citedArtifact": {"identifier": [{"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26244877"}, {"type": {"text": "mid", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "NIHMS719565"}, {"system": "https://www.ncbi.nlm.nih.gov/pmc/", "value": "PMC4562797"}, {"system": "https://doi.org", "value": "10.1056/NEJMoa1503747"}], "relatedIdentifier": [{"assigner": {"display": "ClinicalTrials.gov"}, "system": "https://clinicaltrials.gov", "value": "NCT00309985"}], "title": [{"text": "Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.", "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}, "type": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/title-type", "code": "primary", "display": "Primary title"}]}]}], "abstract": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-aritfact-abstract-type", "code": "primary-human-use", "display": "Primary human use"}]}, "text": "**BACKGROUND:** Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone.\n**METHODS:** We assigned men with metastatic, hormone-sensitive prostate cancer to receive either ADT plus docetaxel (at a dose of 75 mg per square meter of body-surface area every 3 weeks for six cycles) or ADT alone. The primary objective was to test the hypothesis that the median overall survival would be 33.3% longer among patients receiving docetaxel added to ADT early during therapy than among patients receiving ADT alone.\n**RESULTS:** A total of 790 patients (median age, 63 years) underwent randomization. After a median follow-up of 28.9 months, the median overall survival was 13.6 months longer with ADT plus docetaxel (combination therapy) than with ADT alone (57.6 months vs. 44.0 months; hazard ratio for death in the combination group, 0.61; 95% confidence interval [CI], 0.47 to 0.80; P&lt;0.001). The median time to biochemical, symptomatic, or radiographic progression was 20.2 months in the combination group, as compared with 11.7 months in the ADT-alone group (hazard ratio, 0.61; 95% CI, 0.51 to 0.72; P&lt;0.001). The rate of a prostate-specific antigen level of less than 0.2 ng per milliliter at 12 months was 27.7% in the combination group versus 16.8% in the ADT-alone group (P&lt;0.001). In the combination group, the rate of grade 3 or 4 febrile neutropenia was 6.2%, the rate of grade 3 or 4 infection with neutropenia was 2.3%, and the rate of grade 3 sensory neuropathy and of grade 3 motor neuropathy was 0.5%.\n**CONCLUSIONS:** Six cycles of docetaxel at the beginning of ADT for metastatic prostate cancer resulted in significantly longer overall survival than that with ADT alone. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT00309985.)."}], "relatesTo": [{"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293\u20137.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/0/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "0", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Prostate Cancer Trialists\u2019 Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet. 2000;355:1491\u20138.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/10801170/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "10801170", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Samson DJ, Seidenfeld J, Schmitt B, et al. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 2002;95:361\u201376.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/12124837/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "12124837", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Hussain M, Tangen CM, Berry DL, et al. Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med. 2013;368:1314\u201325.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/23550669/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "23550669", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Tangen CM, Hussain MH, Higano CS, et al. Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346) J Urol. 2012;188:1164\u20139.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/22921015/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "22921015", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Wu JN, Fish KM, Evans CP, Devere White RW, Dall\u2019Era MA. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period. Cancer. 2014;120:818\u201323.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/24258693/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "24258693", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351:1513\u201320.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/15470214/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "15470214", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351:1502\u201312.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/15470213/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "15470213", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Millikan RE, Wen S, Pagliaro LC, et al. Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer. J Clin Oncol. 2008;26:5936\u201342.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/19029421/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19029421", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Gravis G, Fizazi K, Joly F, et al. Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial. Lancet Oncol. 2013;14:149\u201358.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/23306100/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "23306100", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med. 1989;321:419\u201324.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/2503724/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "2503724", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Eisenberger MA, Blumenstein BA, Crawford ED, et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med. 1998;339:1036\u201342.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/9761805/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "9761805", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst. 2000;92:205\u201316.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/10655437/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "10655437", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Jennison CTB. Statistical approaches to interim monitoring of medical trials: a review and commentary. Stat Sci. 1990;5:299\u2013317."}, {"type": "cites", "citation": "Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381."}, {"type": "cites", "citation": "Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187\u2013220."}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163\u201370.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/5910392/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "5910392", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Cox D. Analysis of binary data. London: Methuen and Co; 1970."}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364:1995\u20132005.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/21612468/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "21612468", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Ryan CJ, Smith MR, de Bono JS, et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med. 2013;368:138\u201348.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/23228172/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "23228172", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Beer TM, strong AJ, Rathkopf DE, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med. 2014;371:424\u201333.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/24881730/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "24881730", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367:1187\u201397.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/22894553/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "22894553", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411\u201322.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/20818862/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "20818862", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "de Bono JS, Oudard S, Ozguroglu M, et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet. 2010;376:1147\u201354.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/20888992/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "20888992", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369:213\u201323.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/23863050/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "23863050", "assigner": {"display": "NLM"}}}}, {"type": "cites", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article"}]}], "citation": "James ND, Spears MR, Clarke NW, et al. Survival with newly diagnosed metastatic prostate cancer in the \u201cdocetaxel era\u201d: data from 917 patients in the control of the STAMPEDE trial (MRC PR08, CRUK/06/019) Eur Urol. 2015;67:1028\u201338.", "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/25301760/", "type": "Citation", "identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "25301760", "assigner": {"display": "NLM"}}}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "BMJ. 2015 Aug 05;351:h4253. doi: 10.1136/bmj.h4253.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26251343", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26251343/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Nat Rev Clin Oncol. 2015 Oct;12(10):563. doi: 10.1038/nrclinonc.2015.145.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26305034", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26305034/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Nat Rev Urol. 2015 Dec;12(12):656-8. doi: 10.1038/nrurol.2015.255.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26526753", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26526753/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Nat Rev Clin Oncol. 2015 Dec;12(12):687-8. doi: 10.1038/nrclinonc.2015.192.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26552950", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26552950/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "BMC Med. 2015 Dec 22;13:304. doi: 10.1186/s12916-015-0543-9.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26695172", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26695172/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "J Urol. 2016 Jan;195(1):94. doi: 10.1016/j.juro.2015.10.055.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26699961", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26699961/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "N Engl J Med. 2016 Jan 21;374(3):287. doi: 10.1056/NEJMc1511800.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26789883", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26789883/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "N Engl J Med. 2016 Jan 21;374(3):286. doi: 10.1056/NEJMc1511800.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26789884", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26789884/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Eur Urol. 2016 Mar;69(3):540. doi: 10.1016/j.eururo.2015.12.027.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26867727", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26867727/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Eur Urol. 2016 Apr;69(4):755-6. doi: 10.1016/j.eururo.2016.01.020.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26972499", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26972499/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Eur Urol. 2016 Jan;69(1):178. doi: 10.1016/j.eururo.2015.10.037.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "27099882", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/27099882/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Urol Oncol. 2017 Mar;35(3):123. doi: 10.1016/j.urolonc.2016.12.021.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "28159490", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/28159490/"}}], "publicationForm": [{"publishedIn": {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/published-in-type", "code": "D020492", "display": "Periodical"}]}, "identifier": [{"type": {"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "code": "Electronic", "display": "Electronic"}], "text": "Electronic ISSN Type"}, "value": "1533-4406", "system": "https://portal.issn.org"}, {"type": {"text": "ISOAbbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://www.issn.org/services/online-services/access-to-the-ltwa/", "value": "N Engl J Med"}, {"type": {"text": "ISSN Linking", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/", "value": "0028-4793"}, {"type": {"text": "Medline Title Abbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html", "value": "N Engl J Med"}, {"type": {"text": "NLM Unique ID", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local", "value": "0255562"}], "title": "The New England journal of medicine", "publisherLocation": "United States"}, "citedMedium": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-medium", "code": "internet", "display": "Internet"}]}, "volume": "373", "issue": "8", "articleDate": "2015-08-20", "pageString": "737-46", "publicationDateText": "2015-Aug-20"}, {"citedMedium": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-medium", "code": "internet-without-issue", "display": "Internet without issue"}]}, "articleDate": "2015-08-05"}], "webLocation": [{"classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "code": "abstract", "display": "Abstract"}]}], "url": "https://pubmed.ncbi.nlm.nih.gov/26244877/"}, {"url": "https://doi.org/10.1056/NEJMoa1503747", "classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "code": "doi-based", "display": "DOI Based"}]}]}], "classification": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "publishing-model", "display": "Publishing Model", "userSelected": false}]}, "classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code": "Print-Electronic", "display": "Print Electronic", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "chemical", "display": "Chemical", "userSelected": false}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000726", "display": "Androgen Antagonists", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000970", "display": "Antineoplastic Agents", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D043823", "display": "Taxoids", "userSelected": false}]}, {"coding": [{"system": "https://www.cas.org/support/documentation/chemical-substances", "code": "15H5577CQD", "userSelected": false}, {"system": "https://www.nlm.nih.gov/mesh", "code": "D000077143", "display": "Docetaxel", "userSelected": false}]}, {"coding": [{"system": "https://www.cas.org/support/documentation/chemical-substances", "code": "EC 3.4.21.77", "userSelected": false}, {"system": "https://www.nlm.nih.gov/mesh", "code": "D017430", "display": "Prostate-Specific Antigen", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}]}, "artifactAssessment": [{"reference": "#meshHeading0", "type": "ArtifactAssessment"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "publication-type", "display": "Publication type"}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016428", "display": "Journal Article", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016448", "display": "Multicenter Study", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016449", "display": "Randomized Controlled Trial", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D052061", "display": "Research Support, N.I.H., Extramural", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D013485", "display": "Research Support, Non-U.S. Gov't", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "knowledge-artifact-type", "display": "Knowledge Artifact Type", "userSelected": false}]}, "classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code": "D016428", "display": "Journal Article", "userSelected": false}]}], "artifactAssessment": [{"display": "Classifier added by Computable Publishing LLC"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "citation-subset", "display": "Citation subset", "userSelected": false}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "code": "IM", "display": "IM", "userSelected": false}]}]}], "contributorship": {"entry": [{"contributor": {"reference": "#contributor0", "type": "Practitioner", "display": "Sweeney CJ"}, "forenameInitials": "CJ", "affiliation": [{"display": "From the Department of Medicine (C.J.S.) and the Department of Biostatistics and Computational Biology (Y.-H.C.), Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston (C.J.S.); Johns Hopkins University, Baltimore (M.C., M.E.); University of Wisconsin Carbone Cancer Center (G.L., D.F.J.) and School of Medicine and Public Health (D.F.J.), Madison; Fox Chase Cancer Center, Temple University Health System, Philadelphia (Y.-N.W.); Indiana University Melvin and Bren Simon Cancer Center, Indianapolis (N.H.); Mayo Clinic, Rochester, MN (M.K.); University Hospitals Case Medical Center, Seidman Cancer Center (M.M.C.), and Cleveland Clinic Taussig Cancer Institute (J.A.G.) - both in Cleveland; University of Virginia Cancer Center, Charlottesville (R.D.); Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.); Siteman Cancer Center, Washington University School of Medicine, St. Louis (J.P.); NorthShore University HealthSystem, Evanston, IL (D.S.); University of Michigan Comprehensive Cancer Center, Ann Arbor (M.H.); and Rutgers Cancer Institute of New Jersey, New Brunswick (R.S.D.)."}]}, {"contributor": {"reference": "#contributor1", "type": "Practitioner", "display": "Chen YH"}, "forenameInitials": "YH"}, {"contributor": {"reference": "#contributor2", "type": "Practitioner", "display": "Carducci M"}, "forenameInitials": "M"}, {"contributor": {"reference": "#contributor3", "type": "Practitioner", "display": "Liu G"}, "forenameInitials": "G"}, {"contributor": {"reference": "#contributor4", "type": "Practitioner", "display": "Jarrard DF"}, "forenameInitials": "DF"}, {"contributor": {"reference": "#contributor5", "type": "Practitioner", "display": "Eisenberger M"}, "forenameInitials": "M"}, {"contributor": {"reference": "#contributor6", "type": "Practitioner", "display": "Wong YN"}, "forenameInitials": "YN"}, {"contributor": {"reference": "#contributor7", "type": "Practitioner", "display": "Hahn N"}, "forenameInitials": "N"}, {"contributor": {"reference": "#contributor8", "type": "Practitioner", "display": "Kohli M"}, "forenameInitials": "M"}, {"contributor": {"reference": "#contributor9", "type": "Practitioner", "display": "Cooney MM"}, "forenameInitials": "MM"}, {"contributor": {"reference": "#contributor10", "type": "Practitioner", "display": "Dreicer R"}, "forenameInitials": "R"}, {"contributor": {"reference": "#contributor11", "type": "Practitioner", "display": "Vogelzang NJ"}, "forenameInitials": "NJ"}, {"contributor": {"reference": "#contributor12", "type": "Practitioner", "display": "Picus J"}, "forenameInitials": "J"}, {"contributor": {"reference": "#contributor13", "type": "Practitioner", "display": "Shevrin D"}, "forenameInitials": "D"}, {"contributor": {"reference": "#contributor14", "type": "Practitioner", "display": "Hussain M"}, "forenameInitials": "M"}, {"contributor": {"reference": "#contributor15", "type": "Practitioner", "display": "Garcia JA"}, "forenameInitials": "JA"}, {"contributor": {"reference": "#contributor16", "type": "Practitioner", "display": "DiPaola RS"}, "forenameInitials": "RS"}], "complete": true}}, "approvalDate": "2015-08-25", "lastReviewDate": "2024-08-05", "currentState": [{"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "medline-medline", "display": "Medline Citation Status of Medline"}]}, {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-publication-status-ppublish", "display": "PubMed PublicationStatus of ppublish"}]}], "title": "26244877 Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "179616", "assigner": {"display": "Computable Publishing LLC"}}, {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26244877"}], "status": "active", "url": "https://fevir.net/resources/Citation/179616", "id": "179616", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Computable Publishing\u00ae: MEDLINE-to-FEvIR Converter"}], "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code": "active", "display": "Active"}]}}], "description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."}